Insider sale at below market prices questions company valuation. No insider buying in the past year is not overly concerning due to Xylem's profitability and growth. Lower levels of insider ownership call for investor caution.
Pre-Market Stock Movers Gapping up $百思买(BBY.US)$stock rose 1.1% after the electronics retailer reported a smaller-than-expected drop in quarterly comparable sales, as deeper discounts encouraged consumers to shop. $Verizon(VZ.US)$stock rose 1.5% and AT&T (NYSE:T) stock climbed 1.7% after Citigroup upgraded both telecom giants to ‘buy’ from ‘neutral’, saying they support their dividend yields. $甲骨文(ORCL.US)$st...
Deutsche Bank Upgrades$安飞士(CAR.US)$to Buy From Hold, Adjusts Price Target to $263 From $239 Avis Budget Group (CAR) has an average rating of Outperform and price targets ranging from $182 to $327, according to analysts polled by Capital IQ. Wells Fargo Adjusts Price Target on$安霸(AMBA.US)$to $90 From $100, Maintains Overweight Rating Ambarella (AMBA) has an average outperform rating and a price target range of $70 to...
$杜邦(DD.US)$Dr Burry has great foresight as always. Water will be the most important resource of the decade. With daily sustenance n agriculture competing with semiconductor foundries that demands a even higher quality of water of a even larger quantity. Water treatment will enjoy continuous stable demands. Many in this fragmented water treatment industry are either construction companies specialising in building water treatment plant or dealers selling dupont as their own product (like hyfl...
jkak :
it stupid that if you think water will become rare in future. Means your physic teacher never teach you anything about water circulation theory.
Moderna Upgraded to Buy From Hold at Jefferies Jefferies analyst Michael Yee upgraded$Moderna(MRNA.US)$to Buy from Hold with a price target of $275, up from $170. The shares can rebound in 2023 given the company's pipeline opportunities, Yee tells investors in a research note. He believes Moderna is the "new shiny thing" in personalized cancer vaccine following the recent positive Phase 2 data. Atlantic Upgrades Warner Music on 'Solid...
Xylem Upgraded to Overweight From Neutral at Atlantic Equities Atlantic Equities analyst Richard Radbourne upgraded$赛莱默(XYL.US)$to Overweight from Neutral with a price target of $129, up from $110. Supply chain constraints weighed heavily on Xylem during 2022 but these are now easing and should allow the M&CS business to become an earnings tailwind during fiscal 2023, Radbourne tells investors in a research note. Micron Initiated Wit...
Xylem Upgraded to Buy on Municipal Budget Expansion at Cowen Cowen analyst Joseph Giordano upgraded$赛莱默(XYL.US)$to Outperform from Market Perform with a price target of $105, up from $85. Survey work suggests municipal budget expansion at least through fiscal 2023 and utility interviews highlight Xylem as well positioned to lead in smart infrastructure, where backlogs are significant and will pace 2023 revenue growth, Giordano tells...
赛莱默股票讨论区
专栏Today's Pre-Market Stock Movers And Top Ratings: ORCL, BBY, CRM, PDD and More
Gapping up
$百思买(BBY.US)$ stock rose 1.1% after the electronics retailer reported a smaller-than-expected drop in quarterly comparable sales, as deeper discounts encouraged consumers to shop.
$Verizon(VZ.US)$ stock rose 1.5% and AT&T (NYSE:T) stock climbed 1.7% after Citigroup upgraded both telecom giants to ‘buy’ from ‘neutral’, saying they support their dividend yields.
$甲骨文(ORCL.US)$ st...
专栏US Top Gap Ups and Downs on 8/9: AZTA, TOST, DOCS, RBLX and More
Gap Ups
1. $Azenta(AZTA.US)$ - up 14.9%
2. $Toast(TOST.US)$ - up 12.1%
3. $Celsius Holdings(CELH.US)$ - up 9.6%
4. $Axon Enterprise(AXON.US)$ - up 9.2%
5. $Marqeta(MQ.US)$ - up 7.6%
6. $阿克迈(AKAM.US)$ - up 6.1%
7. $Coupang(CPNG.US)$ - up 5.8%
8. $佩恩国民博彩(PENN.US)$ - up 5.3%
9...
专栏US Top Rating Updates on 5/31: CAR, CVX, AMBA, ARGX and More
Avis Budget Group (CAR) has an average rating of Outperform and price targets ranging from $182 to $327, according to analysts polled by Capital IQ.
Wells Fargo Adjusts Price Target on $安霸(AMBA.US)$ to $90 From $100, Maintains Overweight Rating
Ambarella (AMBA) has an average outperform rating and a price target range of $70 to...
目前市盈率45,市盈率TTM 60,缺乏增长数据支持。
专栏US Top Rating Updates on 1/24: XYL, LYFT, AMD, VFC and More
专栏US Top Rating Updates on 12/19: TSLA, T, MRNA, XYL and More
Jefferies analyst Michael Yee upgraded $Moderna(MRNA.US)$ to Buy from Hold with a price target of $275, up from $170. The shares can rebound in 2023 given the company's pipeline opportunities, Yee tells investors in a research note. He believes Moderna is the "new shiny thing" in personalized cancer vaccine following the recent positive Phase 2 data.
Atlantic Upgrades Warner Music on 'Solid...
专栏US Top Rating Updates on 11/16: MU, QCOM, HD, XYL and More
Atlantic Equities analyst Richard Radbourne upgraded $赛莱默(XYL.US)$ to Overweight from Neutral with a price target of $129, up from $110. Supply chain constraints weighed heavily on Xylem during 2022 but these are now easing and should allow the M&CS business to become an earnings tailwind during fiscal 2023, Radbourne tells investors in a research note.
Micron Initiated Wit...
专栏US Top Rating Updates on 10/18: ABT, MDT, DXCM, XYL and More
Cowen analyst Joseph Giordano upgraded $赛莱默(XYL.US)$ to Outperform from Market Perform with a price target of $105, up from $85. Survey work suggests municipal budget expansion at least through fiscal 2023 and utility interviews highlight Xylem as well positioned to lead in smart infrastructure, where backlogs are significant and will pace 2023 revenue growth, Giordano tells...
暂无评论